FGEN
Price
$0.48
Change
+$0.08 (+20.00%)
Updated
Dec 23, 04:59 PM (EDT)
69 days until earnings call
INSM
Price
$70.57
Change
+$0.13 (+0.18%)
Updated
Dec 23, 04:59 PM (EDT)
58 days until earnings call
Ad is loading...

FGEN vs INSM

Header iconFGEN vs INSM Comparison
Open Charts FGEN vs INSMBanner chart's image
FibroGen
Price$0.48
Change+$0.08 (+20.00%)
Volume$68.43K
CapitalizationN/A
Insmed
Price$70.57
Change+$0.13 (+0.18%)
Volume$19.31K
CapitalizationN/A
FGEN vs INSM Comparison Chart
Loading...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FGEN vs. INSM commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGEN is a Buy and INSM is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 24, 2024
Stock price -- (FGEN: $0.48 vs. INSM: $70.59)
Brand notoriety: FGEN and INSM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGEN: 196% vs. INSM: 60%
Market capitalization -- FGEN: $40.31M vs. INSM: $12.63B
FGEN [@Biotechnology] is valued at $40.31M. INSM’s [@Biotechnology] market capitalization is $12.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGEN’s FA Score shows that 0 FA rating(s) are green whileINSM’s FA Score has 1 green FA rating(s).

  • FGEN’s FA Score: 0 green, 5 red.
  • INSM’s FA Score: 1 green, 4 red.
According to our system of comparison, INSM is a better buy in the long-term than FGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FGEN’s TA Score shows that 5 TA indicator(s) are bullish while INSM’s TA Score has 3 bullish TA indicator(s).

  • FGEN’s TA Score: 5 bullish, 4 bearish.
  • INSM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, FGEN is a better buy in the short-term than INSM.

Price Growth

FGEN (@Biotechnology) experienced а +47.65% price change this week, while INSM (@Biotechnology) price change was -3.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.75%. For the same industry, the average monthly price growth was -2.52%, and the average quarterly price growth was +3.67%.

Reported Earning Dates

FGEN is expected to report earnings on Mar 03, 2025.

INSM is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-1.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($12.6B) has a higher market cap than FGEN($40.3M). INSM YTD gains are higher at: 127.783 vs. FGEN (-45.842). FGEN has higher annual earnings (EBITDA): -101.15M vs. INSM (-769.56M). INSM has more cash in the bank: 1.47B vs. FGEN (131M). FGEN has less debt than INSM: FGEN (79.3M) vs INSM (1B). INSM has higher revenues than FGEN: INSM (343M) vs FGEN (180M).
FGENINSMFGEN / INSM
Capitalization40.3M12.6B0%
EBITDA-101.15M-769.56M13%
Gain YTD-45.842127.783-36%
P/E RatioN/AN/A-
Revenue180M343M52%
Total Cash131M1.47B9%
Total Debt79.3M1B8%
FUNDAMENTALS RATINGS
FGEN vs INSM: Fundamental Ratings
FGEN
INSM
OUTLOOK RATING
1..100
8172
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
10017
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6341
P/E GROWTH RATING
1..100
55100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INSM's Valuation (81) in the Biotechnology industry is in the same range as FGEN (94). This means that INSM’s stock grew similarly to FGEN’s over the last 12 months.

INSM's Profit vs Risk Rating (17) in the Biotechnology industry is significantly better than the same rating for FGEN (100). This means that INSM’s stock grew significantly faster than FGEN’s over the last 12 months.

INSM's SMR Rating (100) in the Biotechnology industry is in the same range as FGEN (100). This means that INSM’s stock grew similarly to FGEN’s over the last 12 months.

INSM's Price Growth Rating (41) in the Biotechnology industry is in the same range as FGEN (63). This means that INSM’s stock grew similarly to FGEN’s over the last 12 months.

FGEN's P/E Growth Rating (55) in the Biotechnology industry is somewhat better than the same rating for INSM (100). This means that FGEN’s stock grew somewhat faster than INSM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FGENINSM
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
71%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 6 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
CTSI.X0.1594820.010661
+7.16%
Cartesi cryptocurrency
SUSHI.X1.5401010.102326
+7.12%
SushiSwap cryptocurrency
MLN.X21.1200050.816305
+4.02%
Enzyme cryptocurrency
OM.X3.7669710.070389
+1.90%
MANTRA cryptocurrency
DOCK.X0.003636-0.000024
-0.65%
Dock cryptocurrency

FGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, FGEN has been loosely correlated with AVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if FGEN jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGEN
1D Price
Change %
FGEN100%
+20.00%
AVTX - FGEN
57%
Loosely correlated
+2.02%
AXON - FGEN
43%
Loosely correlated
-1.20%
BMRN - FGEN
41%
Loosely correlated
+0.93%
INSM - FGEN
39%
Loosely correlated
+0.21%
CMRX - FGEN
35%
Loosely correlated
+1.00%
More

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+0.21%
THAR - INSM
74%
Closely correlated
+0.97%
SRPT - INSM
44%
Loosely correlated
+1.42%
AGIO - INSM
41%
Loosely correlated
-0.20%
VERA - INSM
41%
Loosely correlated
-0.68%
AXON - INSM
40%
Loosely correlated
-1.20%
More